Analysis of the technological park of Brazil for breast cancer screening
DOI:
https://doi.org/10.33448/rsd-v11i15.37075Keywords:
Breast cancer screening; Mammography; Screening; SUS.Abstract
Breast cancer screening in Brazil is carried out, as a priority, opportunistically, through mammographic examinations. The objective was to quantitatively describe the technology park available for breast cancer screening during mammography (MMs) and mammographic examinations (MMG). This is a quantitative study, which analyzed official and public access databases from 2015 to 2021. The number of MM in use is extracted from the National Registry of Health Establishments (CNES), despite the proportion of women served by health plans (PS), data from the National Supplementary Health Agency (ANS), and the estimation of the objective population (PA) of the Department of Informatics of the SUS (DATASUS), from which the number of SUS approved mammograms (MMG) is also extracted. It was concluded that there is an excess of MMs in use to serve the PA throughout Brazil and its regions, with the largest number in the Southeast and the smallest in the North. Among the Federation Units (UF), São Paulo had the highest number of devices in use. Acre, Roraima and Amapá presented the smallest number of devices in use of the SUS. As for the states with less MMs in use under the SUS, Roraima, Acre, Amapá and Tocantins stood out, all from 2015 to 2021, and Alagoas, in 2018. Of the UFs, they noted a lack of MMs to serve both populations, during some years of the analyzed period: Acre and Distrito Federal. The MMG exams approved by the SUS did not reach the coverage target of 50% of the PA ED.
References
Batista, G. de J., Barros, G. G., Abreu, R. A. F. de, Mota, J. S. P., Caetano, I. de O., Santana, G. S., Miranda, M. R., Barroso, A. C. F., Silva, I. H. S. da, Tavares, I. N., & Rocha, A. C. S. (2021). Impacto da mamografia de rastreio na identificação de preditores do câncer de mama no Estado do Tocantins. Research, Society and Development, 10(6), e3110615307. https://doi.org/10.33448/rsd-v10i6.15307
Bernards, R., & Weinberg, R. A. (2002). Metastasis genes: A progression puzzle. Nature, 418(6900), 823–823. https://doi.org/10.1038/418823a
Brasil. (2017). Critérios e Parâmetros Assistenciais para o Planejamento e Programação de Ações e Serviços de Saúde no âmbito do SUS. Ministério Da Saúde. Série Parâmetros SUS, 1, 2–16. https://www.gov.br/saude/pt-br/acesso-a-informacao/gestao-do-sus/programacao-regulacao-controle-e-financiamento-da-mac/programacao-assistencial/arquivos/caderno-1-criterios-e-parametros-assistenciais-1-revisao.pdf
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492
Cunha, G. N. da, Vianna, C. M. de M., Mosegui, G. B. G., Silva, M. P. R. da, & Jardim, F. N. (2018). Rastreamento do câncer de mama: modelo de melhoria do acesso pelo uso de mamógrafos móveis. Revista Panamericana de Salud Pública, 43, 1. https://doi.org/10.26633/RPSP.2019.19
Freitas-Junior, R., Cristina Netto Rodrigues, D., Silveira Corrêa, R., Fernando Pádua Oliveira, L., Soares Couto, L., Augusta Brolini Dellê Urban, L., & Macedo Sousa Rahal, R. (2020). Opportunistic mammography screening by the Brazilian Unified Health System in 2019. Mastology, 30, 20190030. https://doi.org/10.29289/25945394202020190030
Gebrim, L. H. (2016). A detecção precoce do câncer de mama no Brasil. Cadernos de Saúde Pública, 32(5), 516–523. https://doi.org/10.1590/0102-311XCO010516
Goossens, M., De Brabander, I., De Grève, J., Van Ongeval, C., Martens, P., Van Limbergen, E., & Kellen, E. (2019). Flemish breast cancer screening programme: 15 years of key performance indicators (2002-2016). BMC Cancer, 19(1), 1012. https://doi.org/10.1186/s12885-019-6230-z
IARC. (2017). Breast Cancer Screening (W. Press (ed.); 2a, Vol. 15). IARC Working Group on the Evaluation of Cancer-Preventive Strategies.
INCA. (2019). Atualização em mamografia para técnicos em radiologia. https://www.inca.gov.br/publicacoes/livros/atualizacao-em-mamografia-para-tecnicos-em-radiologia
INCA. (2020). Estimativa 2020. https://www.inca.gov.br/estimativa/introducao
INCA. (2021). PARÂMETROS TÉCNICOS PARA O RASTREAMENTO DO CÂNCER DE MAMA. http://controlecancer.bvs.br/
Köche, J. C. (2011). Fundamentos de Metodologia Científica.Vozes. https://btux.com.br/professorbruno/wp-content/uploads/sites/10/2018/07/K%C3%B6che-Jos%C3%A9-Carlos0D0AFundamentos-de-metodologia-cient%C3%ADfica-_-teoria-da0D0Aci%C3%AAncia-e-inicia%C3%A7%C3%A3o-%C3%A0-pesquisa.pdf
Mattos, J. S. de C. (2011). Impacto do rastreamento mamográfico em mulheres de 40 a 49 anos da região de Barretos - SP [Biblioteca Digital de Teses e Dissertações da Universidade de São Paulo]. https://doi.org/10.11606/T.5.2011.tde-24052011-171444
Migowski, A., Dias, M. B. K., Nadanovsky, P., Azevedo E Silva, G., Sant’Ana, D. R., & Stein, A. T. (2018). Guidelines for early detection of breast cancer in Brazil. III – Challenges for implementation. Cadernos de Saude Publica, 34(6). https://doi.org/10.1590/0102-311X00046317
Renck, D. V., Barros, F., Domingues, M. R., Gonzalez, M. C., Sclowitz, M. L., Caputo, E. L., & Gomes, L. de M. (2014). Equidade no acesso ao rastreamento mamográfico do câncer de mama com intervenção de mamógrafo móvel no sul do Rio Grande do Sul, Brasil. Cadernos de Saúde Pública, 30(1), 88–96. https://doi.org/10.1590/0102-311X00017113
Rodrigues, D. C. N., Freitas-Junior, R., Rahal, R. M. S., da Silveira Corrêa, R., Gouveia, P. A., Peixoto, J. E., Martins, E., & Soares, L. R. (2019). Temporal changes in breast cancer screening coverage provided under the Brazilian National Health Service between 2008 and 2017. BMC Public Health, 19(1), 959. https://doi.org/10.1186/s12889-019-7278-z
Segri, N. J. (2013). Estimativas, ajustes e técnicas estatísticas em inquéritos de saúde [Biblioteca Digital de Teses e Dissertações da Universidade de São Paulo]. https://doi.org/10.11606/T.6.2013.tde-02042013-104046
Silva, R. C. F., & Hortale, V. A. (2012). Rastreamento do Câncer de Mama no Brasil : Quem , Como e Por quê ? Breast cancer Screening in Brazil : Who , How and Why ? Revista Brasileira de Cancerologia, 58(1), 67–71. http://www.inca.gov.br/rbc/n_58/v01/pdf/10b_artigo_opiniao_rastreamento_cancer_mama_brasil_quem_como_por_que.pdf
Teixeira, L. A., & Neto, L. A. A. (2020). Breast cancer in Brazil: Medicine and public health in 20th century. Saude e Sociedade, 29(3), 1–12. https://doi.org/10.1590/S0104-12902020180753
Vilas-Lobo, G. R., Santos, R. da S., & Silva, R. R. da. (2022). Mamografia de rastreamento no SUS antes e durante a Pandemia de Covid-19: uma comparação entre biênios. Research, Society and Development, 11(10), e210111032738. https://doi.org/10.33448/rsd-v11i10.32738
WHO. (2007). WHO guide for effective programmes: Early detection. Cancer Control: Knowledge into Action, 3–39. https://www.ncbi.nlm.nih.gov/books/NBK195408/pdf/Bookshelf_NBK195408.pdf%0Ahttps://books.google.com.tr/books?hl=tr&lr=&id=3hVf8Ewh8xUC&oi=fnd&pg=PA2&dq=WHO+breast+cancer+target+group+%2570+who&ots=a7ByYtb_Yi&sig=c6RXwPitlX_bEyj4hmRyazNpP78&redir_esc=y#v=o
WHO. (2020a). Cancer Today. GLOBOCAN. https://gco.iarc.fr/today/online-analysis-table?v=2020&mode=population&mode_population=hdi&population=900&populations=900&key=asr&sex=2&cancer=20&type=1&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&group_cancer=1&incl
WHO. (2020b). Who Report on Cancer. World Health Organization. https://apps.who.int/iris/handle/10665/330745
Wild, C. P., Weiderpass, E., & Stewart, B. W. (2020). Cancer research for cancer prevention World Cancer Report. http://publications.iarc.fr/586.
Xavier, D. R., Oliveira, R. A. D. de, Matos, V. P. de, Viacava, Fr., & Carvalho, C. de C. (2016). Cobertura de mamografias, alocação e uso de equipamentos nas Regiões de Saúde. Saúde Em Debate, 40(110), 20–35. https://doi.org/10.1590/0103-1104201611002
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Glaucia Ribeiro Vilas-Lobo; Ricardo da Silva Santos; Robson Rodrigues da Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
